Joyce M. Annichino-Bizzacchi
Joyce M. Annichino-Bizzacchi has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Antonio de Padua Mansur
Serviço de Prevencao, Cardiopatia na Mulher e Reabilitação Cardiovascular, Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo 05403-900, SP, Brazil
2 shared publications Andrea Origa
1 shared publicationEleanor Pollak
1 shared publicationFernando Costa
1 shared publicationFrancisco Aranha
1 shared publication- José Antonio Franchini Ramires
Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Brasil
1 shared publication
Latest Publications
- 1 January 2004
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 92 (08) , 384-386
Platelet glycoprotein Ibα polymorphisms modulate the risk for myocardial infarction
Schattauer GmbH - Verlag für Medizin und Naturwissenschaften ist ein renommierter Herausgeber von Fachbüchern, -zeitschriften und -software. Besuchen Sie unser Internetangebot mit Onlinezugang zu unseren Zeitschriftenartikeln
- 1 January 2004
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 92 (08) , 384-386
Platelet glycoprotein Ibα polymorphisms modulate the risk for myocardial infarction
Schattauer GmbH - Verlag für Medizin und Naturwissenschaften ist ein renommierter Herausgeber von Fachbüchern, -zeitschriften und -software. Besuchen Sie unser Internetangebot mit Onlinezugang zu unseren Zeitschriftenartikeln
- Open Access
- 1 February 2000
- Published by Oxford University Press (OUP) in European Journal of Cardiovascular Risk
- Vol. 7 (1) , 37-40
C282Y mutation in the HLA-H Gene is Not a Risk Factor for Patients with Myocardial Infarction
Iron is suspected to play a role in the development of atherosclerosis and in the progression of the disease, and consequently in myocardial infarction. Authors of a recent study identified a mutation in HLA-H gene, C282Y, that is an excellent marker for hemochromatosis, which is the most common cause of iron overload. There is a high prevalence of carriers of heterozygous hemochromatosis, most of whom are asymptomatic even with abnormalities of iron metabolism. To study C282Y mutation in the HLA-H gene of 173 survivors of myocardial infarction matched with 172 controls by age, race, and sex, and 119 patients upon diagnosis of acute myocardial infarction. Identification of the mutation was performed by PCR amplification of the DNA fragment followed by Rsal digestion. The prevalence of heterozygotes for the mutated allele both among patients and among controls was 1.74%. None of the 119 patients studied upon diagnosis was a carrier of the mutation. Our data suggested that the most common cause of iron overload is not associated with myocardial infarction.
- 1 February 2000
- Published by Oxford University Press (OUP) in European Journal of Cardiovascular Risk
- Vol. 7 (1) , 37-40
Open AccessC282Y mutation in the HLA-H Gene is Not a Risk Factor for Patients with Myocardial Infarction
Iron is suspected to play a role in the development of atherosclerosis and in the progression of the disease, and consequently in myocardial infarction. Authors of a recent study identified a mutation in HLA-H gene, C282Y, that is an excellent marker for hemochromatosis, which is the most common cause of iron overload. There is a high prevalence of carriers of heterozygous hemochromatosis, most of whom are asymptomatic even with abnormalities of iron metabolism. To study C282Y mutation in the HLA-H gene of 173 survivors of myocardial infarction matched with 172 controls by age, race, and sex, and 119 patients upon diagnosis of acute myocardial infarction. Identification of the mutation was performed by PCR amplification of the DNA fragment followed by Rsal digestion. The prevalence of heterozygotes for the mutated allele both among patients and among controls was 1.74%. None of the 119 patients studied upon diagnosis was a carrier of the mutation. Our data suggested that the most common cause of iron overload is not associated with myocardial infarction.
- 1 October 1999
- Published by Elsevier in Thrombosis Research
- Vol. 96 (1) , 73-76
Hereditary Hemorrhagic Telangiectasia Response to Aminocaproic Acid Treatment
- 1 October 1999
- Published by Elsevier in Thrombosis Research
- Vol. 96 (1) , 73-76
Hereditary Hemorrhagic Telangiectasia Response to Aminocaproic Acid Treatment